MADHAVBAUG Stock Overview
Vaidya Sane Ayurved Laboratories Limited engages in the procurement and sale of medicines and medical equipment in India.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 5/6 |
| Dividends | 2/6 |
Vaidya Sane Ayurved Laboratories Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹180.00 |
| 52 Week High | ₹376.95 |
| 52 Week Low | ₹162.00 |
| Beta | 0.096 |
| 1 Month Change | -3.25% |
| 3 Month Change | -7.22% |
| 1 Year Change | -21.74% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 70.78% |
Recent News & Updates
Shareholder Returns
| MADHAVBAUG | IN Healthcare | IN Market | |
|---|---|---|---|
| 7D | -4.5% | -1.6% | -3.7% |
| 1Y | -21.7% | 53.4% | 38.4% |
Return vs Industry: MADHAVBAUG underperformed the Indian Healthcare industry which returned 55.6% over the past year.
Return vs Market: MADHAVBAUG underperformed the Indian Market which returned 41.4% over the past year.
Price Volatility
| MADHAVBAUG volatility | |
|---|---|
| MADHAVBAUG Average Weekly Movement | 7.0% |
| Healthcare Industry Average Movement | 6.4% |
| Market Average Movement | 6.6% |
| 10% most volatile stocks in IN Market | 9.8% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: MADHAVBAUG has not had significant price volatility in the past 3 months.
Volatility Over Time: MADHAVBAUG's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 632 | Rohit Sane | madhavbaug.org |
Vaidya Sane Ayurved Laboratories Limited engages in the procurement and sale of medicines and medical equipment in India. It operates through Sale of Product Activity and Hospital Activity. The company is also involved in the operation of cardiac care clinics and hospitals.
Vaidya Sane Ayurved Laboratories Limited Fundamentals Summary
| MADHAVBAUG fundamental statistics | |
|---|---|
| Market cap | ₹1.89b |
| Earnings (TTM) | ₹32.79m |
| Revenue (TTM) | ₹1.05b |
57.7x
P/E Ratio1.8x
P/S RatioIs MADHAVBAUG overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MADHAVBAUG income statement (TTM) | |
|---|---|
| Revenue | ₹1.05b |
| Cost of Revenue | ₹317.63m |
| Gross Profit | ₹729.19m |
| Other Expenses | ₹696.41m |
| Earnings | ₹32.79m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 3.12 |
| Gross Margin | 69.66% |
| Net Profit Margin | 3.13% |
| Debt/Equity Ratio | 7.3% |
How did MADHAVBAUG perform over the long term?
See historical performance and comparison